JAZZ vs KNSL · P/E 1988, rev $2.28B vs P/E 13, rev $1.02B
Jazz Pharmaceuticals PLC (JAZZ) versus Kinsale Capital Group Inc (KNSL) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Kinsale Capital Group Inc (KNSL) is a insurance - property & casualty company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported KNSL revenue for 2026-06-30 was $1.02B. Net income was $288.4M. KNSL currently screens at market cap $7.06B and trailing P/E 13.5.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. KNSL currently screens at market cap $7.06B and trailing P/E 13.5.
Not investment advice. Open the JAZZ and KNSL stock pages for the full models.
Not investment advice.